Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$73.76 - $85.98 $37,838 - $44,107
-513 Reduced 9.6%
4,831 $394,000
Q1 2023

May 12, 2023

SELL
$71.62 - $86.62 $60,733 - $73,453
-848 Reduced 13.7%
5,344 $396,000
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $296,946 - $1.3 Million
3,681 Added 146.59%
6,192 $513,000
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $64,701 - $89,733
229 Added 10.04%
2,511 $713,000
Q2 2022

Aug 15, 2022

BUY
$322.67 - $449.65 $97,123 - $135,344
301 Added 15.19%
2,282 $791,000
Q1 2022

May 11, 2022

BUY
$353.85 - $487.79 $29,015 - $39,998
82 Added 4.32%
1,981 $858,000
Q4 2021

Feb 14, 2022

SELL
$456.15 - $525.06 $6,842 - $7,875
-15 Reduced 0.78%
1,899 $982,000
Q3 2021

Nov 15, 2021

SELL
$444.87 - $538.88 $27,581 - $33,410
-62 Reduced 3.14%
1,914 $927,000
Q2 2021

Aug 16, 2021

BUY
$387.35 - $450.26 $2,324 - $2,701
6 Added 0.3%
1,976 $890,000
Q2 2020

Aug 14, 2020

SELL
$185.43 - $279.56 $18,543 - $27,956
-100 Reduced 4.83%
1,970 $520,000
Q1 2020

May 13, 2020

SELL
$161.17 - $221.51 $331,526 - $455,646
-2,057 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$183.56 - $216.72 $1,468 - $1,733
-8 Reduced 0.39%
2,057 $402,000
Q2 2019

Aug 12, 2019

BUY
$188.72 - $215.43 $389,706 - $444,862
2,065 New
2,065 $431,000
Q3 2018

Nov 14, 2018

SELL
$147.44 - $204.11 $211,281 - $292,489
-1,433 Closed
0 $0
Q2 2018

Aug 13, 2018

SELL
$144.9 - $165.58 $200,106 - $228,665
-1,381 Reduced 49.08%
1,433 $212,000
Q1 2018

May 14, 2018

SELL
$131.46 - $151.04 $278,432 - $319,902
-2,118 Reduced 42.94%
2,814 $425,000
Q4 2017

Feb 13, 2018

BUY
$121.17 - $134.75 $26,293 - $29,240
217 Added 4.6%
4,932 $639,000
Q3 2017

Nov 14, 2017

BUY
$113.59 - $123.78 $535,576 - $583,622
4,715
4,715 $570,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.59B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Veritable, L.P. Portfolio

Follow Veritable, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.